The CiRA Foundation has a policy and review committee on how cells are provided to institutes and industries. Factors considered include the research proposal, business plan, ethical approval, etc.
Organizations that desire use of the iPSC stock are requested to return the completed application form and other documents to the e-mail address below.
The review committee will evaluate the documents and render the decision.
Please fill in the appropriate form below and send it
by email to ips-stock-shinsa*cira-foundation.or.jp.
(Please Change * to @)
【For Principal investigators】
(Form1) Application for iPS cell stock use
【For Co-Principal investigators】
(Form 1-1) Application for collaborative research patner
Once we have received your application form, we will contact you
within 7 business days.
If you do not hear from us after 7 days, please contact us again
at the above email.
・Terms and Conditions for use of the iPS cell stock
Please check the following URL to see if you meet the conditions.
(Each PDF is only one or two pages.)
Examination standards for the use of the iPS cell stock
Basic Policies for the supply of the iPS cell stock
Please go to the FAQ page for these information.
If you have any questions, please contact
ips-stock-shinsa*cira-foundation.or.jp (Change * to @).
We are happy to answer questions before submission
of your documents.
The Stock Committee Office will check if your application meets
the examination standards and national regulations.
After your application is approved by the Stock Committee Office,
our staff in charge of contracts will send you a draft contract.
At this point, all companies need to conclude a license agreement
with iPS Academia Japan, Inc.
Click here for the iPS Academia Japan website.
We will issue an invoice after signing the joint research agreement.
Click for prices.
iPS Cell Stock Review Committee
（CiRA Foundation Planning Office）
Please change * to @
It is not the same organization. Please refer to the web page for the information.
We operate as a public interest incorporated foundation, not as a stock company. We do not "sell" iPS cells, but provide them to non-profit institutions free of charge and to for-profit institutions at a low price as a "joint research fee."
Please note that we cannot provide cells for purchase only, only for collaborative research.
Please also note that the initial cost of the iPS cells is 50,000 yen for research-grade and 100,000 yen for clinical-grade, but partners are required to pay 50 million yen at the time of approval as an ownership transfer fee. (This cost is half for ventures and is a one-time payment for partners.) An information maintenance fee will also be charged. (0.5% of worldwide sales for 20 years from the year following approval.)
In Japan, even when using donor-derived iPS cells for basic research, it is necessary to follow the regulations in "Ethical Guidelines for Medical Research Involving Human Subjects."
This is also required of overseas research institutions that receive our iPS cells. Please click the link for more information.
Since the number of clinical level iPS cells is limited, we ask users to please select the most suitable iPS cell line for their purpose first with research iPS cells.
It is possible. The transfer will be done after the clinical trial notification.
Please click the link for more information.